Elrig

APRIL 29, 2024

Co-Chair: Millie Fox Co-Chair: Millie Fox Senior Drug Discovery Scientist, AstraZeneca Millie graduated from the University of Sussex with a Biochemistry degree in 2016, which included an industrial placement year at GSK, Stevenage. Bioinformatics is all about bringing together different areas of knowledge.

Bioinformatics 59

Bioinformatics Molecular Biology Drugs Cell Based Assays 59

Drug Discovery World

OCTOBER 17, 2022

As a backdrop to this informatics ecosystem, it can be helpful to tap into a set of guiding principles established in 2016 to support improved scientific data management and stewardship, the FAIR Principles. . Volume 23 – Issue 4, Fall 2022 . Reference: . About the author .

Marketing 130

Marketing Molecular Biology Bioinformatics Science 130

Drug Discovery World

AUGUST 16, 2022

However, these social categories are rather arbitrary and don’t necessarily correspond to the underlying molecular biology of the patient, risking misguided clinical care. Instead, molecular markers are more accurate indicators of the patient’s associated risks. . People are beautifully different.

Research 130

Research Clinical Trials Trials Drug Development 130

Codon

JULY 27, 2023

in Current Biology. There’s a TV show where a bunch of doctors are walking through a hospital corridor. ” Wellcome Collection , London I wrapped up my series on “30 Days of Great Biology Papers.” This minimal cell, first reported in 2016, was about half as fit as a normal M. From McKyton et al.

Therapies 52

Therapies RNA DNA Engineering 52

Codon

JULY 27, 2023

in Current Biology. There’s a TV show where a bunch of doctors are walking through a hospital corridor. ” Wellcome Collection , London I wrapped up my series on “30 Days of Great Biology Papers.” This minimal cell, first reported in 2016, was about half as fit as a normal M. From McKyton et al.

Therapies 52

Therapies RNA DNA Engineering 52

Codon

FEBRUARY 13, 2024

” A Global View Even as advances in computing and molecular biology usher in the era of a new, high-tech “phage therapy 2.0”, Doctors commonly encounter at least 13 or 14 bacterial species with drug-resistant strains across a range of infections in different parts of the body. UTIs, diabetic foot ulcers).

Therapies 138

Therapies DNA Virus Clinical Trials 138